CeGaT GmbH
Detlef Schumann is an experienced executive in the biomedical field, currently serving as Chief Executive Officer at TETEC Tissue Engineering Technologies AG since September 2020, where efforts focus on reversing company underperformance and introducing contract manufacturing services for pharma and biotech. Additionally, Schumann holds the position of Managing Director at CeGaT GmbH since April 2021, representing B. Braun. Previous roles include Vice President of Front End Innovation at BBraun Aesculap, where strategic partnerships and laboratory improvements were managed, and various positions at DSM Biomedical focusing on business development and R&D in regenerative medicine. Schumann's academic background includes postdoctoral research at MIT and Harvard Medical School, as well as a PhD from the University of Regensburg, where contributions to tissue engineering and mechanobiology were made.
This person is not in any teams
CeGaT GmbH
1 followers
We are a world leader in gene analyses for a wide range of medical, research and pharmaceutical applications. Since 2009, we have been helping doctors and patients find the genetic causes of rare diseases. We provide researchers and pharmaceutical companies with genetic analysis for clinical trials and medical innovation. We help oncologists and cancer patients find the best therapy option. We continue to drive science forward with our own insights. You can find our imprint under the following link: https://www.cegat.de/en/disclaimer/ Sie finden unser Impressum unter folgendem Link: https://www.cegat.de/impressum/